Skip to main content
SpringerLink
Log in

Sulphasalazine in the Long Term Management of Rheumatoid Arthritis

  • Section 3: Outcome Measures and Long Term Assessment
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The clinical outcome of rheumatoid arthritis patients treated long term with sulphasalazine or parenteral gold was studied. The rate of withdrawal from gold because of inefficacy was less frequent than that for patients receiving sulphasalazine. However, patients on sulphasalazine withdrew less frequently because of adverse reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bax DE, Amos RS. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Annals of the Rheumatic Diseases 44: 194–198, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bird HA, Dixon JS, Pickup ME, Rhind VM, Lowe JR. A biochemical assessment of sulphasalazine in rheumatoid arthritis. Journal of Rheumatology 9: 36–45, 1982

    PubMed  CAS  Google Scholar 

  • McConkey B, Amos RS, Butler EP, Crockson RS, Crockson AP, Walsh L. Salazopyrin in rheumatoid arthritis. Agents and Actions 8: 438–441, 1978

    Article  PubMed  CAS  Google Scholar 

  • McConkey B, Amos RS, Durham S, Forster PJG, Hubball S, Walsh L. Sulphasalazine in rheumatoid arthritis. British Medical Journal 280: 442–444, 1980

    Article  PubMed  CAS  Google Scholar 

  • Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis. British Medical Journal 287: 1099–1102, 1983

    Article  PubMed  CAS  Google Scholar 

  • Pullar T, Hunter JA, Capell HA. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. British Medical Journal 287: 1102–1104, 1983

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Nether Edge Hospital, Sheffield, S11 9EL, UK

    D. E. Bax & R. S. Amos

Authors
  1. D. E. Bax
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. S. Amos
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Enteric-coated sulphasalazine was used in this study; marketed by Pharmacia Ltd as Salazopyrin® EN-tabs, Azulfidine® EN-tabs® (USA), Azulfidine RA® (Germany).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bax, D.E., Amos, R.S. Sulphasalazine in the Long Term Management of Rheumatoid Arthritis. Drugs 32 (Suppl 1), 73–76 (1986). https://doi.org/10.2165/00003495-198600321-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198600321-00016

Keywords

Search

Navigation